Sodium phosphate dibasic dodecahydrate CAS:10039-32-4

  • Product Name:Sodium phosphate dibasic dodecahydrate
  • CAS:10039-32-4
  • Molecular formula:H25Na2O16P
  • Contact Supplier

Poroduct Description

Files Download:

COA:Downl oad

Sodium phosphate dibasic dodecahydrate CAS:10039-32-4

Sodium phosphate dibasic dodecahydrate CAS:10039-32-4 Basic information

Product Name: Sodium phosphate dibasic dodecahydrate
Synonyms: di-Sodium hydrogen phosphate dodecahydrate for analysis EMSURE ISO,Reag. Ph Eur;SODIUM PHOSPHATE DIBASIC DODECAHYDRA;Dibasic Sodium Phosphate Dodecahydrate;Sodium Phosphate Dibasic Dodecahydrate, Meets analytical specification of Ph.Eur.BP;DI-SODIUM HYDRO
CAS: 10039-32-4
MF: H25Na2O16P
MW: 358.14
EINECS: 600-088-6
Product Categories: Food Additives
Mol File: 10039-32-4.mol

Sodium phosphate dibasic dodecahydrate CAS:10039-32-4 Chemical Properties

density: 1,52 g/cm3
Melting point: 35 °C
form: Crystals
storage temp.: Store at +15°C to +25°C.
Water Solubility: 218 g/L (20 ºC)
InChIKey: DGLRDKLJZLEJCY-UHFFFAOYSA-L
solubility: H2O: 0.1 M at 20 °C, clear, colorless
Odor: Odorless
λmax: λ: 260 nm Amax: 0.01λ: 280 nm Amax: 0.01
CAS DataBase Reference: 10039-32-4(CAS DataBase Reference)
EPA Substance Registry System: Disodium phosphate dodecahydrate (10039-32-4)

PARTICULAR

PARAMETER


Content(On the base of dry basis)≥%

98.0

98.3

As         %

0.0003

<0.0003

Heave metals(as pb)   %

0.001

<0.001

Loss on drying(Na2HPO4.2H2O)≤%

18.0-22.0

19.3

Water Insolubles        %

0.1

0.05

F              %

0.005

<0.004

Pb             %

0.0002

<0.0002

Conclusion

Qualified

Sodium phosphate dibasic dodecahydrate Usage And Synthesis
Chemical Propertieswhite crystals
Chemical PropertiesThe USP 32 states that dibasic sodium phosphate is dried or contains, 1, 2, 7, or 12 molecules of water of hydration. Anhydrous dibasic sodium phosphate occurs as a white powder. The dihydrate occurs as white or almost white, odorless crystals.
The heptahydrate occurs as colorless crystals or as a white granular or caked salt that effloresces in warm, dry air. The dodecahydrate occurs as strongly efflorescent, colorless or transparent crystals.
UsesLaxative.
Production MethodsEither bone phosphate (bone ash), obtained by heating bones to whiteness, or the mineral phosphorite is used as a source of tribasic calcium phosphate, which is the starting material in the industrial production of dibasic sodium phosphate.
Tribasic calcium phosphate is finely ground and digested with sulfuric acid. This mixture is then leached with hot water and neutralized with sodium carbonate, and dibasic sodium phosphate is crystallized from the filtrate.
DefinitionChEBI: A hydrate that is the dodecahydrate form of disodium hydrogenphosphate
Pharmaceutical ApplicationsDibasic sodium phosphate is used in a wide variety of pharmaceutical formulations as a buffering agent and as a sequestering agent. Therapeutically, dibasic sodium phosphate is used as a mild laxative and in the treatment of hypophosphatemia.
Dibasic sodium phosphate is also used in food products; for example as an emulsifier in processed cheese.
SafetyDibasic sodium phosphate is widely used as an excipient in parenteral, oral, and topical pharmaceutical formulations. Phosphate occurs extensively in the body and is involved in many physiological processes since it is the principal anion of intracellular fluid. Most foods contain adequate amounts of phosphate, making hypophosphatemia (phosphate deficiency) virtually unknown except for certain disease states or in patients receiving total parenteral nutrition. Treatment is usually by the oral administration of up to 100 mmol of phosphate daily.
Approximately two-thirds of ingested phosphate is absorbed from the gastrointestinal tract, virtually all of it being excreted in the urine, and the remainder is excreted in the feces.
Excessive administration of phosphate, particularly intravenously, rectally, or in patients with renal failure, can cause hyperphosphatemia that may lead to hypocalcemia or other severe electrolyte imbalances. Adverse effects occur less frequently following oral consumption, although phosphates act as mild saline laxatives when administered orally or rectally. Consequently, gastrointestinal disturbances including diarrhea, nausea, and vomiting may occur following the use of dibasic sodium phosphate as an excipient in oral formulations. However, the level of dibasic sodium phosphate used as an excipient in a pharmaceutical formulation is not usually associated with adverse effects.
LD50 (rat, oral): 17 g/kg
storageThe anhydrous form of dibasic sodium phosphate is hygroscopic. When heated to 40℃, the dodecahydrate fuses; at 100℃ it loses its water of crystallization; and at a dull-red heat (about 240℃) it is converted into the pyrophosphate, Na4P2O7. Aqueous solutions of dibasic sodium phosphate are stable and may be sterilized by autoclaving.
The bulk material should be stored in an airtight container, in a cool, dry place.
IncompatibilitiesDibasic sodium phosphate is incompatible with alkaloids, antipyrine, chloral hydrate, lead acetate, pyrogallol, resorcinol and calcium gluconate, and ciprofloxacin. Interaction between calcium and phosphate, leading to the formation of insoluble calcium-phosphate precipitates, is possible in parenteral admixtures.
Regulatory StatusGRAS listed. Accepted in Europe for use as a food additive. Included in the FDA Inactive Ingredients Database (injections; infusions; nasal, ophthalmic, oral, otic, topical, and vaginal preparations). Included in nonparenteral and parenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.


You need any help?

Related Content

Isavuconazonium sulfate CAS:946075-13-4

Isavuconazonium sulfate CAS:94…

CATHARANTHINE SULFATE CAS:70674-90-7

CATHARANTHINE SULFATE CAS:7067…

urea phosphate CAS:4401-74-5

urea phosphate CAS:4401-74-5

potassium 3-hydroxybutyrate CAS:39650-04-9

potassium 3-hydroxybutyrate CA…

sodium hydrogen adipate CAS:18996-34-4

sodium hydrogen adipate CAS:18…

Potassium 4-methoxysalicylate CAS:152312-71-5

Potassium 4-methoxysalicylate …

Kieserite CAS:14567-64-7

Kieserite CAS:14567-64-7

Guanidinium dihydrogen phosphate CAS:5423-22-3

Guanidinium dihydrogen phospha…

Piperaquine phosphate CAS:4085-31-8

Piperaquine phosphate CAS:4085…

AMMONIUM (META)TUNGSTATE HYDRATE CAS:12333-11-8

AMMONIUM (META)TUNGSTATE HYDRA…

AMMONIUM PENTABORATE EXTRA PURE CAS:12229-12-8

AMMONIUM PENTABORATE EXTRA PUR…

SODIUM HYPOPHOSPHITE MONOHYDRATE CAS:123333-67-5

SODIUM HYPOPHOSPHITE MONOHYDRA…

Isoprenaline sulphate CAS:299-95-6

Isoprenaline sulphate CAS:299-…

BARIUM IODATE CAS:7787-34-0

BARIUM IODATE CAS:7787-34-0

ZINC BORATE CAS:10361-94-1

ZINC BORATE CAS:10361-94-1

Address:303 FUTURE CITY,LIXIA DISTRICT,JINAN CITY,SHANDONG PROVINCE,CHINA Post Encoding:250000 Email:sales@bosschemical.com
Tel:8613280017993 Mobile:8613280017993 Fax:86-531-68657995

Link